PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 7, 2026British Journal of Haematology0 citations

Risk of thromboembolism in patients with metastatic renal cell carcinoma treated with combination‐based immunotherapy

View Full Paper
YCYu‐Cheng ChangHLHao-Kuen LinJPJoseph Piwowarski

Key Points

  • This research aims to evaluate the risk of thromboembolism in patients with metastatic renal cell carcinoma undergoing combination-based immunotherapy.
  • Utilized propensity score matching to analyze the risk of thromboembolism among patients.
  • Examined disease and outcome definitions to ensure accurate data categorization.
  • Provided supporting data available upon request.
  • Detailed findings on thromboembolism risk during immunotherapy were articulated.
  • Specific event rates and statistical measures were not disclosed in the abstract.

Abstract

The data supporting this study's findings are available upon reasonable request from the corresponding author. Table S1. Disease and outcome definitions. Table S2. Variables used in the propensity score matching model. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Chang et al. (2026) studied this question.

synapsesocial.com/papers/69fc2ba98b49bacb8b347a91https://doi.org/10.1111/bjh.70526
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology2024 · 179 citations
  2. 2Comparative evaluation of cardiovascular risks among nine FDA-approved VEGFR-TKIs in patients with solid tumors: a Bayesian network analysis of randomized controlled trials2021 · 59 citations
  3. 3Cabozantinib and thromboembolism in patients with cancer: a systematic review, meta-analysis, and retrospective study2025 · 5 citations
  4. 4Risk of Thromboembolism in Patients Receiving Immunotherapy-Based Combinations as Front-Line Therapy for Metastatic Renal Cell Carcinoma2023 · 4 citations
  5. 5Variable Selection for Propensity Score Models2006 · 2,361 citations